Is HJ worth the price difference against Zhuhai Kerui Biotechnology on measured results?

The case in front of me: HJ · Zhuhai Kerui Biotechnology.

These are treated as interchangeable and I do not think they are.

If both are acceptable I would like to know that, so I can stop thinking about it.

What is the actual trade-off, and does it matter at the scale I am working at?

Answer first: comparing suppliers is only meaningful if the comparison holds the laboratory, the method and the compound constant, and most published comparisons hold none of them.

Lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.

On the detail: publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

No supplier on this site pays for its position, and the storefront links are marked nofollow and sponsored.

One laboratory, one method, one submission. Otherwise it is not a comparison.

Answering this needs the axis. A supplier that is best on paperwork and a supplier that is best on price are both correct answers to different questions.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

Specifically, cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Use a fixed documentation checklist rather than an impression.

Concretely, a single member running three suppliers on one method is worth more than thirty members running one supplier each.

Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

Gradient slope, column chemistry and detection wavelength all affect the reported purity figure, which is why the method section is the part that makes results comparable.

Price per milligram of measured peptide, not per milligram of label claim.

Start by asking what you are optimising for, because cost per milligram, documentation depth and lead time do not have a common winner.

To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.

Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.

Name the laboratory and the dates or the comparison cannot be reproduced.

edited 10 Mar 2025 by tandem_gradient — removed a claim I could not source